Vascular peptide endothelin-1 links fat accumulation with alterations of visceral adipocyte lipolysis

Diabetes

Volumn 57, Issue 2, 2008, Pages 378-386

  Van Harmelen, Vanessa ^a   Eriksson, Anna ^a   Åström, Gaby ^a   Wåhlén, Kerstin ^a   Näslund, Erik ^b   Karpe, Fredrik ^c   Frayn, Keith ^c   Olsson, Tommy ^d   Andersson, Jonas ^d   Rydén, Mikel ^a   Arner, Peter ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b DANDERYD HOSPITAL   (Sweden)

^c CHURCHILL HOSPITAL   (United Kingdom)

^d UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CALMODULIN; ENDOTHELIN 1; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR B; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; PHOSPHODIESTERASE 3B; PHOSPHODIESTERASE III; PROTEIN KINASE C; UNCLASSIFIED DRUG; INSULIN RECEPTOR SUBSTRATE 1 PROTEIN; INSULIN RECEPTOR SUBSTRATE-1 PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ABDOMINAL SUBCUTANEOUS FAT; ADIPOCYTE; ADIPOSE TISSUE; ADULT; ARTICLE; BLOOD SAMPLING; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAABDOMINAL FAT; LIPID STORAGE; LIPOLYSIS; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SURGICAL TECHNIQUE; AGED; BLOOD; BODY MASS; GENE EXPRESSION REGULATION; GENETICS; INSULIN RESISTANCE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; REFERENCE VALUE; RNA INTERFERENCE; SECRETION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADIPOCYTES; ADULT; AGED; BODY MASS INDEX; ENDOTHELIN-1; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INSULIN RESISTANCE; LIPOLYSIS; MALE; MIDDLE AGED; OBESITY; REFERENCE VALUES; RNA INTERFERENCE;

EID: 40749132624     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db07-0893     Document Type: Article

References (38)

1. Fantuzzi G, Mazzone T: Adipose tissue and atherosclerosis: exploring the connection. Arterioscler Thromb Vasc Biol 27:996-1003, 2007
2. Sowers JR: Obesity as a cardiovascular risk factor. Am J Med 115 (Suppl. 8A):37S-41S, 2003
3. Arner P: The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones. Trends Endocrinol Metab 14:137-145, 2003
4. Arner P: Human fat cell lipolysis: biochemistry, regulation and clinical role. Best Pract Res Clin Endocrinol Metab 19:471-482, 2005
5. Langin D: Control of fatty acid and glycerol release in adipose tissue lipolysis. C R Biol 329:598 -607, 2006 [discussion 653-595]
6. Zierath JR, Livingston JN, Thorne A, Bolinder J, Reynisdottir S, Lonnqvist F, Arner P: Regional difference in insulin inhibition of non-esterified fatty acid release from human adipocytes: relation to insulin receptor phosphorylation and intracellular signalling through the insulin receptor substrate-1 pathway. Diabetologia 41:1343-1354, 1998
7. Bolinder J, Kager L, Ostman J, Arner P: Differences at the receptor and postreceptor levels between human omental and subcutaneous adipose tissue in the action of insulin on lipolysis. Diabetes 32:117-123, 1983
8. Livingston JN, Lerea KM, Bolinder J, Kager L, Backman L, Arner P: Binding and molecular weight properties of the insulin receptor from omental and subcutaneous adipocytes in human obesity. Diabetologia 27:447-453, 1984
9. Ferri C, Bellini C, Desideri G, Baldoncini R, Properzi G, Santucci A, De Mattia G: Circulating endothelin-1 levels in obese patients with the metabolic syndrome. Exp Clin Endocrinol Diabetes 105 (Suppl 2):38-40, 1997
10. Parrinello G, Scaglione R, Pinto A, Corrao S, Cecala M, Di Silvestre G, Amato P, Licata A, Licata G: Central obesity and hypertension: the role of plasma endothelin. Am J Hypertens 9:1186-1191, 1996
11. Haak T, Jungmann E, Felber A, Hillmann U, Usadel KH: Increased plasma levels of endothelin in diabetic patients with hypertension. Am J Hyper-tens 5:161-166, 1992
12. Schneider JG, Tilly N, Hierl T, Sommer U, Hamann A, Dugi K, Leidig-Bruckner G, Kasperk C: Elevated plasma endothelin-1 levels in diabetes mellitus. Am J Hypertens 15:967-972, 2002
13. Touyz RM, Schiffrin EL: Role of endothelin in human hypertension. Can J Physiol Pharmacol 81:533-541, 2003
14. Hauner H, Petruschke T, Gries FA: Endothelin-1 inhibits the adipose differentiation of cultured human adipocyte precursor cells. Metabolism 43:227-232, 1994
15. Usui I, Imamura T, Babendure JL, Satoh H, Lu JC, Hupfeld CJ, Olefsky JM: G protein-coupled receptor kinase 2 mediates endothelin-1-induced insulin resistance via the inhibition of both Galphaq/11 and insulin receptor substrate-1 pathways in 3T3-L1 adipocytes. Mol Endocrinol 19:2760-2768, 2005
16. Ishibashi KI, Imamura T, Sharma PM, Huang J, Ugi S, Olefsky JM: Chronic endothelin-1 treatment leads to heterologous desensitization of insulin signaling in 3T3-L1 adipocytes. J Clin Invest 107:1193-1202, 2001
17. Sokolovsky M: Endothelin receptor subtypes and their role in transmembrane signaling mechanisms. Pharmacol Ther 68:435-471, 1995
18. Sokolovsky M: Endothelin receptor heterogeneity, G-proteins, and signaling via cAMP and cGMP cascades. Cell Mol Neurobiol 15:561-571, 1995
19. Bouallegue A, Daou GB, Srivastava AK: Endothelin-1-induced signaling pathways in vascular smooth muscle cells. Curr Vasc Pharmacol 5:45-52, 2007
20. Dahlman I, Kaaman M, Olsson T, Tan GD, Bickerton AS, Wahlen K, Andersson J, Nordstrom EA, Blomqvist L, Sjogren A, Forsgren M, Atter-sand A, Arner P: A unique role of monocyte chemoattractant protein 1 among chemokines in adipose tissue of obese subjects. J Clin Endocrinol Metab 90:5834-5840, 2005
21. Frayn KN, Coppack SW: Assessment of white adipose tissue metabolism by measurement of arteriovenous differences. Methods Mol Biol 155:269-279, 2001
22. van Harmelen V, Skurk T, Hauner H: Primary culture and differentiation of human adipocyte precursor cells. Methods Mol Med 107:125-135, 2005
23. Hellmer J, Arner P, Lundin A: Automatic luminometric kinetic assay of glycerol for lipolysis studies. Anal Biochem 177:132-137, 1989
24. Ryden M, Dicker A, van Harmelen V, Hauner H, Brunnberg M, Perbeck L, Lonnqvist F, Arner P: Mapping of early signaling events in tumor necrosis factor-alpha-mediated lipolysis in human fat cells. J Biol Chem 277:1085-1091, 2002
25. Gabrielsson BG, Olofsson LE, Sjogren A, Jernas M, Elander A, Lonn M, Rudemo M, Carlsson LM: Evaluation of reference genes for studies of gene expression in human adipose tissue. Obes Res 13:649-652, 2005
26. Sarafidis PA, Bakris GL: Insulin and endothelin: an interplay contributing to hypertension development? J Clin Endocrinol Metab 92:379-385, 2007
27. Wilkes JJ, Hevener A, Olefsky J: Chronic endothelin-1 treatment leads to insulin resistance in vivo. Diabetes 52:1904-1909, 2003
28. Trayhurn P, Wood IS: Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92:347-355, 2004
29. Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM: Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA 91:4854-4858, 1994
30. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM: IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271:665-668, 1996
31. Juan CC, Chang CL, Lai YH, Ho LT: Endothelin-1 induces lipolysis in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 288:E1146-E1152, 2005
32. Juan CC, Chang LW, Huang SW, Chang CL, Lee CY, Chien Y, Hsu YP, Ho PH, Chen YC, Ho LT: Effect of endothelin-1 on lipolysis in rat adipocytes. Obesity (Silver Spring) 14:398-404, 2006
33. Gual P, Le Marchand-Brustel Y, Tanti JF: Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 87:99 -109, 2005
34. Adams M, Montague CT, Prins JB, Holder JC, Smith SA, Sanders L, Digby JE, Sewter CP, Lazar MA, Chatterjee VK, O'Rahilly S: Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation. J Clin Invest 100:3149-3153, 1997
35. Shaw SG, Boden PJ: Insulin resistance, obesity and the metabolic syndrome: is there a therapeutic role for endothelin-1 antagonists? Curr Vasc Pharmacol 3:359-363, 2005
36. Ahlborg G, Shemyakin A, Bohm F, Gonon A, Pernow J: Dual endothelin receptor blockade acutely improves insulin sensitivity in obese patients with insulin resistance and coronary artery disease. Diabetes Care 30:591-596, 2007
37. Davenport AP, Maguire JJ: Endothelin. Handb Exp Pharmacol 295-329, 2006
38. Tchkonia T, Giorgadze N, Pirtskhalava T, Thomou T, DePonte M, Koo A, Forse RA, Chinnappan D, Martin-Ruiz C, von Zglinicki T, Kirkland JL: Fat depot-specific characteristics are retained in strains derived from single human preadipocytes. Diabetes 55:2571-2578, 2006